Alfredo Torres Gonzalez, M.D
Hematology & Oncology Physician in Port Jefferson Station, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
Alfredo Torres Gonzalez, M.D reported a CMS MIPS final score of 99.2/100 - above the 83.5 national average - and filed 2,024 Medicare Part D claims in 2023.
- 99.2/100
- MIPS score · +16 vs avg
- 2K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
- ≥91st
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Alfredo Torres Gonzalez, M.D's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
99 ≥ 91st percentile 91% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Alfredo Torres Gonzalez, M.D sits
This provider among hematology & oncology physician peers
Across the 4,019 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Alfredo Torres Gonzalez, M.D writes more Part D claims than 91% of them and scores higher on MIPS quality than 89% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Alfredo Torres Gonzalez, M.D. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Alfredo Torres Gonzalez, M.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Alfredo Torres Gonzalez, M.D?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Hematology & Oncology Physician compares to other specialties among New York providers
Hematology & Oncology Physician ranks #70 among New York's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the New York provider total, by primary NUCC taxonomy. The highlighted bar is Hematology & Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Alfredo Torres Gonzalez, M.D's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 99.2/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Specialty volume Hematology & Oncology Physician US NPIs
99.2/100 MIPS final score - 15.7 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Hematology & Oncology Physician.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Alfredo Torres Gonzalez, M.D appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D credentials at 1500 ROUTE 112 STE 101, Port Jefferson Station, NY, 11776, with a listed phone of (631) 751-3000. NPI 1285977546 was issued on 04/04/2013.
Medicare Part D records for calendar year 2023 show 2,024 prescription claims written by this provider, covering 271 Medicare beneficiaries and totaling roughly $8.6 million in drug spend, with an opioid prescribing rate of 3.7%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.2/100 for the 2023 performance year, compared with the 83.5 average among clinicians with a measured score.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,232 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1285977546 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D |
| Gender | Male |
| NPI Issued | 04/04/2013 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Alfredo Torres Gonzalez, M.D's current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1285977546 is the unique 10-digit identifier CMS uses to link Torres Gonzalez across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Alfredo Torres Gonzalez, M.D bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Alfredo Torres Gonzalez, M.D. Source: openpaymentsdata.cms.gov.
Total received
$65.9K
Largest payer
GENZYME CORPORATION
Most common payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Alfredo Torres Gonzalez, M.D. To verify Alfredo Torres Gonzalez, M.D's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,828
- Total Day Supply
- 76,955
- Generic Drug Cost
- $515K
- Opioid Claims
- 75 (3.7% rate)
- Antibiotic Claims
- 51
Patient Demographics
- Average Patient Age
- 74.9 years
- Avg HCC Risk Score
- 2.25
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 26, 65-74: 96, 75-84: 114, 85+: 35
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Alfredo Torres Gonzalez, M.D prescribes most
Top Medicare Part D drugs by claim count, 2023
- Aranesp
Aranesp
169 claims
- Prednisone
Prednisone
148 claims
- Eliquis
Eliquis
86 claims
- Lupron Depot
Lupron Depot
71 claims
- Ibrance 54
Ibrance
54 claims
- Darzalex Faspro 52
Darzalex Faspro
52 claims
- Abiraterone Acetate 50
Abiraterone Acetate
50 claims
- Xgeva 49
Xgeva
49 claims
| Drug | Claims |
|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 169 |
| Prednisone | 148 |
| Eliquis Apixaban | 86 |
| Lupron Depot Leuprolide Acetate | 71 |
| Ibrance Palbociclib | 54 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 52 |
| Abiraterone Acetate | 50 |
| Xgeva Denosumab | 49 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 47 |
| Exemestane | 40 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Alfredo Torres Gonzalez, M.D fits within the Hematology & Oncology Physician landscape nationally.
Alfredo Torres Gonzalez, M.D's 2,024 claims are above the specialty average of 847.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Torres Gonzalez, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (99.2 here).
Same NPPES enumeration year (2013)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Torres Gonzalez.
One of 967 Hematology & Oncology Physician providers enrolled in New York, 5 are shown here.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is Alfredo Torres Gonzalez, M.D's specialty? ▼
How much does Alfredo Torres Gonzalez, M.D prescribe under Medicare Part D? ▼
What is Alfredo Torres Gonzalez, M.D's Medicare quality score? ▼
Where is Alfredo Torres Gonzalez, M.D located? ▼
What is Alfredo Torres Gonzalez, M.D's NPI number? ▼
Does Alfredo Torres Gonzalez, M.D prescribe opioids? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does Alfredo Torres Gonzalez, M.D prescribe most often? ▼
Does Alfredo Torres Gonzalez, M.D accept Medicare? ▼
How can I verify Alfredo Torres Gonzalez, M.D's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.